Form 8-K · Current report
Clorox 8-K, filed Aug 3, 2026
- Filed
- CIK
- 0000021076
- Accession no.
- 0000021076-26-000028
Summary
The Clorox Company reported fourth-quarter and fiscal 2026 results on August 3, 2026, with fourth-quarter net sales down 2% to $1.95 billion (organic sales down 13%), diluted EPS down 50% to $1.34 and adjusted EPS down 42% to $1.66, which Chair and CEO Linda Rendle said were in line with expectations. Clorox guided fiscal 2027 net sales up 13% to 14%, including about 9.5 points from its April 2026 acquisition of GOJO Industries, and said it expects a challenging operating environment with cost volatility and a value-seeking consumer.
Key points
- Clorox completed the acquisition of GOJO Industries in April 2026; GOJO now operates as Clorox Purell, and the company's global health and hygiene portfolio now represents more than half of net sales.
- Fourth-quarter gross margin fell 520 basis points to 41.3%, hit by lower volume, GOJO inventory step-up, and higher commodity, manufacturing and logistics costs.
- Fiscal year 2026 net sales fell 5% to $6.72 billion and adjusted EPS fell 28% to $5.53, with organic sales down 8%, largely due to lapping retailers' pre-ERP inventory build.
- Clorox completed its U.S. ERP implementation and implemented a simplified operating structure during fiscal 2026, and expects lapping the ERP-related inventory drawdown to add more than 3.5 points to fiscal 2027 net sales growth.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition On August 3, 2026, The Clorox Company issued a press release announcing its financial results for its fourth quarter and fiscal year ended June 30, 2026. The full text of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. Item 7.01 Regulation FD Disclosure Attached hereto as Exhibit 99.2 and incorporated herein by reference is supplemental financial information. Item 9.01 Financial Statements and Exhibits (d) Exhibits See the Exhibit Index below. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.